rs1568507
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000529461.1(WNT11):c.-172-1320A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.33 in 152,156 control chromosomes in the GnomAD database, including 8,544 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.33 ( 8544 hom., cov: 33)
Consequence
WNT11
ENST00000529461.1 intron
ENST00000529461.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.801
Publications
1 publications found
Genes affected
WNT11 (HGNC:12776): (Wnt family member 11) The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It encodes a protein which shows 97%, 85%, and 63% amino acid identity with mouse, chicken, and Xenopus Wnt11 protein, respectively. This gene may play roles in the development of skeleton, kidney and lung, and is considered to be a plausible candidate gene for High Bone Mass Syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.533 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| WNT11 | XM_011545238.2 | c.-91-1777A>T | intron_variant | Intron 1 of 5 | XP_011543540.1 | |||
| WNT11 | XM_011545239.3 | c.-91-1777A>T | intron_variant | Intron 1 of 5 | XP_011543541.1 | |||
| WNT11 | XM_011545240.3 | c.-172-1320A>T | intron_variant | Intron 1 of 6 | XP_011543542.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.330 AC: 50177AN: 152038Hom.: 8523 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
50177
AN:
152038
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.330 AC: 50244AN: 152156Hom.: 8544 Cov.: 33 AF XY: 0.335 AC XY: 24925AN XY: 74368 show subpopulations
GnomAD4 genome
AF:
AC:
50244
AN:
152156
Hom.:
Cov.:
33
AF XY:
AC XY:
24925
AN XY:
74368
show subpopulations
African (AFR)
AF:
AC:
11279
AN:
41538
American (AMR)
AF:
AC:
5729
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
1229
AN:
3468
East Asian (EAS)
AF:
AC:
2828
AN:
5140
South Asian (SAS)
AF:
AC:
2033
AN:
4818
European-Finnish (FIN)
AF:
AC:
3953
AN:
10606
Middle Eastern (MID)
AF:
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21855
AN:
67972
Other (OTH)
AF:
AC:
744
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1792
3583
5375
7166
8958
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1683
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.